Threonine 80 on HLA-B27 confers protection against lysis by a group of natural killer clones.
Recognition of major histocompatibility complex (MHC) class I molecules on target cells by natural killer (NK) cells inhibits NK cell-mediated lysis. Although it is known that this inhibitory effect is regulated by MHC polymorphism, the precise structural determinants remain undefined. Based on the capacity of different HLA-C and HLA-B motifs specifically to inhibit cytotoxicity of some NK clones, three different NK cell specificities (NK1, NK2 and NK3) have been described. In this study, the recognition of HLA-B27 by NK clones has been analyzed using C1R cells transfected with different HLA-B27 subtypes as target cells. Cytotoxicity was inhibited by the HLA-B*2705, -B*2701 -B*2703, -B*2704 and -B*2706 alleles, but not by -B*2702. This subtype is distinguished from the other B27 subtypes by the presence of isoleucine instead of threonine at position 80. Direct involvement of this residue was assessed by showing that site-directed mutagenesis of Thr80 to Ile80 in HLA-B*2705 reverted the NK protective effect of HLA-B*2705. Based on these data, we suggest that Thr80 could act as a single residue conferring target cell protection from lysis by a group of NK clones, tentatively designated NK4.
Luque
I
I
Departamento de Inmunología, Facultad de Medicina, Hospital Reina Sofía, Universidad de Córdoba, Spain.
Solana
R
R
Galiani
M D
MD
González
R
R
García
F
F
López de Castro
J A
JA
Peña
J
J
D000328:Adult; D000483:Alleles; D000595:Amino Acid Sequence; D002999:Clone Cells; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D015796:HLA-B27 Antigen / Q000737:chemistry* / Q000145:classification / Q000235:genetics; D006801:Humans; D007694:Killer Cells, Natural / Q000187:drug effects*; D008213:Lymphocyte Activation; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D013912:Threonine / Q000235:genetics / Q000502:physiology*
D015796:HLA-B27 Antigen; D013912:Threonine